We are live on ! Find out more
SXL

Summit X LLC Portfolio holdings

AUM $536M
1-Year Est. Return 15.36%
This Fund
S&P 500
This Quarter Est. Return
+10.68%
1 Year Est. Return
+15.36%
3 Year Est. Return
+62.88%
5 Year Est. Return
+106.61%
10 Year Est. Return
AUM
$6.1M
AUM Growth
-$264M
Cap. Flow
+$29.4M
Cap. Flow %
481.7%
Top 10 Hldgs %
52.57%
Holding
453
New
240
Increased
120
Reduced
70
Closed
4

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 33.37%
2 Technology 9.09%
3 Communication Services 8.94%
4 Financials 6.31%
5 Healthcare 4.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HAIN icon
426
Hain Celestial
HAIN
$47.8M
$206 ﹤0.01%
+681
New +$22.6K
ETN icon
427
Eaton
ETN
$157B
$204 ﹤0.01%
+508
New +$49.7K
PH icon
428
Parker-Hannifin
PH
$125B
$202 ﹤0.01%
+9
New +$1.77K
UTHR icon
429
United Therapeutics
UTHR
$26.3B
$202 ﹤0.01%
+120
New +$13.2K
DRI icon
430
Darden Restaurants
DRI
$22.5B
$201 ﹤0.01%
+142
New +$11.8K
CGC
431
Canopy Growth
CGC
$375M
$200 ﹤0.01%
+178
New +$29.9K
F icon
432
Ford
F
$57.3B
$107 ﹤0.01%
14,969
+2,045
+16% +$13.8K
ISEE
433
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$73 ﹤0.01%
12,850
-150
-1% -$715
GERN icon
434
Geron
GERN
$911M
$64 ﹤0.01%
149,778
+5,780
+4% +$10.7K
ACH
435
Accendra Health
ACH
$240M
$25 ﹤0.01%
20,000
+10,000
+100% +$146K
LYG icon
436
Lloyds Banking Group
LYG
$87.4B
$17 ﹤0.01%
20,508
-2,194
-10% -$3.08K
TRVN
437
DELISTED
Trevena, Inc.
TRVN
$9 ﹤0.01%
76
-48
-39% -$63.2K
NMTR
438
DELISTED
9 Meters Biopharma
NMTR
$9 ﹤0.01%
2,150
+250
+13% +$3.03K
LCTX icon
439
Lineage Cell Therapeutics
LCTX
$257M
$2 ﹤0.01%
29,000
SNGX icon
440
Soligenix
SNGX
$5.5M
$2 ﹤0.01%
58
SER icon
441
Serina Therapeutics
SER
$31M
$2 ﹤0.01%
668
+170
+34% +$6.07K
DNN icon
442
Denison Mines
DNN
$2.63B
$1 ﹤0.01%
11,000
EYPT icon
443
EyePoint Inc
EYPT
$1.02B
$1 ﹤0.01%
2,550
KOPN icon
444
Kopin
KOPN
$663M
$1 ﹤0.01%
22,000
+5,000
+29% +$7.72K
VSTM icon
445
Verastem
VSTM
$532M
$1 ﹤0.01%
1,833
XXII
446
22nd Century Group
XXII
$1.47M
0
CWBR
447
DELISTED
CohBar, Inc. Common Stock
CWBR
$1 ﹤0.01%
667
+200
+43% +$8.03K
ATNM icon
448
Actinium Pharmaceuticals
ATNM
$27M
-2,273
Closed -$24K
BGT icon
449
BlackRock Floating Rate Income Trust
BGT
$322M
-10,939
Closed -$120K
CENN icon
450
Cenntro
CENN
$8.24M
-1
Closed

Similar funds

Summit X LLC's Q3 2020 Portfolio in Review

As of Q3 2020, Summit X LLC held 453 positions worth $6.1M, down 98% from $270M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Summit X LLC deployed $29.4M of net new capital in Q3 2020, opening 240 new positions and adding to 120 existing holdings. Its largest new stake was Centene: 48,721 shares worth $17.6K.

By sector, the portfolio is most concentrated in Consumer Discretionary at 33% of assets, up from 7.8% a quarter earlier, followed by Technology and Communication Services.

On the sell side, the largest reduction was iShares Core Dividend Growth ETF, an estimated $1.62M trimmed.

  • Summit X LLC's largest Q3 2020 buy was Centene: 48,721 shares worth $17.6K.
  • Summit X LLC added most to Amazon in Q3 2020, an estimated $2.1M increase.
  • Summit X LLC's biggest Q3 2020 reduction was iShares Core Dividend Growth ETF, cutting an estimated $1.62M.
  • Summit X LLC fully exited BlackRock Floating Rate Income Trust in Q3 2020, selling an estimated $120K.
  • Summit X LLC's ten largest holdings make up 53% of its $6.1M portfolio in Q3 2020.
  • Summit X LLC opened 240 new positions and closed 4 in Q3 2020.
  • Summit X LLC's portfolio value fell 98% quarter-over-quarter to $6.1M.

Based on Summit X LLC's 13F filing for Q3 2020, filed 12 Nov 2020.